13F
中

USPH U.S. PHYSICAL THERAPY INC

2026Q1 · CUSIP 90337L108 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
225
Δ holders QoQ
-1
Breadth percentile
Top 66%
Whale holders
118
Δ whales
0
Inst. holding value
$1.1B
New positions
29
Closed positions
30
Price momentum (1Q)
-24.4%
Put / Call
1/2

Breadth history (34 quarters)

2018Q1: Δ+9 · h=176 2018Q2: Δ+10 · h=186 2018Q3: Δ+9 · h=195 2018Q4: Δ+0 · h=195 2019Q1: Δ+22 · h=217 2019Q2: Δ-6 · h=211 2019Q3: Δ+4 · h=215 2019Q4: Δ-3 · h=212 2020Q1: Δ-16 · h=196 2020Q2: Δ-12 · h=184 2020Q3: Δ-1 · h=183 2020Q4: Δ+20 · h=203 2021Q1: Δ+7 · h=210 2021Q2: Δ+7 · h=217 2021Q3: Δ-8 · h=209 2021Q4: Δ-1 · h=208 2022Q1: Δ-1 · h=207 2022Q2: Δ-5 · h=202 2022Q3: Δ-6 · h=196 2022Q4: Δ+0 · h=196 2023Q1: Δ+4 · h=200 2023Q2: Δ+12 · h=212 2023Q3: Δ+4 · h=216 2023Q4: Δ-5 · h=211 2024Q1: Δ+22 · h=233 2024Q2: Δ+8 · h=241 2024Q3: Δ+13 · h=254 2024Q4: Δ+0 · h=254 2025Q1: Δ-3 · h=251 2025Q2: Δ-13 · h=238 2025Q3: Δ+6 · h=244 2025Q4: Δ-18 · h=226 2026Q1: Δ-1 · h=225 2018Q1: holders=176 2018Q2: holders=186 2018Q3: holders=195 2018Q4: holders=195 2019Q1: holders=217 2019Q2: holders=211 2019Q3: holders=215 2019Q4: holders=212 2020Q1: holders=196 2020Q2: holders=184 2020Q3: holders=183 2020Q4: holders=203 2021Q1: holders=210 2021Q2: holders=217 2021Q3: holders=209 2021Q4: holders=208 2022Q1: holders=207 2022Q2: holders=202 2022Q3: holders=196 2022Q4: holders=196 2023Q1: holders=200 2023Q2: holders=212 2023Q3: holders=216 2023Q4: holders=211 2024Q1: holders=233 2024Q2: holders=241 2024Q3: holders=254 2024Q4: holders=254 2025Q1: holders=251 2025Q2: holders=238 2025Q3: holders=244 2025Q4: holders=226 2026Q1: holders=225 -22 -11 +0 +11 +22 158213267 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q1 Top 13% -21.0% -14.4%
2023Q2 Top 18% -13.4% -2.1%
2019Q1 Top 13% +16.8% +0.0%

Options Sentiment

Put holders
1
QoQ: -2
Call holders
2
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
138.7
EPS (TTM)
$0.50
EPS YoY
-77.1%
Revenue (TTM)
$0.8B
Revenue YoY
+13.7%
Quarterly Revenue & EPS (4Y)
2022-06-30: $141M 2022-09-30: $140M 2022-12-31: $141M 2023-03-31: $149M 2023-06-30: $151M 2023-09-30: $150M 2023-12-31: $155M 2024-03-31: $156M 2024-06-30: $167M 2024-09-30: $168M 2024-12-31: $180M 2025-03-31: $184M 2025-06-30: $197M 2025-09-30: $197M 2025-12-31: $203M 2026-03-31: $198M 2022-06-30: EPS 0.87 2022-09-30: EPS 0.72 2022-12-31: EPS -0.01 2023-03-31: EPS 0.58 2023-06-30: EPS 0.64 2023-09-30: EPS 0.51 2023-12-31: EPS -0.45 2024-03-31: EPS 0.46 2024-06-30: EPS 0.47 2024-09-30: EPS 0.39 2024-12-31: EPS 0.52 2025-03-31: EPS 0.80 2025-06-30: EPS 0.58 2025-09-30: EPS 0.48 2025-12-31: EPS -0.44 2026-03-31: EPS -0.12 0M 101M 203M $M -0.50 0.23 0.96 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 49 2023-03-31: PE 48.52023-06-30: PE 49.22023-09-30: PE 472023-12-31: PE 75.22024-03-31: PE 87.42024-06-30: PE 81.22024-09-30: PE 99.72024-12-31: PE 45.62025-03-31: PE 35.52025-06-30: PE 36.52025-09-30: PE 29.52025-12-31: PE 60.42026-03-31: PE 124.7 27 79 131 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)